CONFLUENCE PHARMACEUTICALS LLC has a total of 26 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals are ICDPHARMA LTD, Enspire Group LLC and Xiong Xingxuan.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Republic of Korea | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Canada | 2 | |
#7 | Hong Kong | 2 | |
#8 | Israel | 2 | |
#9 | Singapore | 2 | |
#10 | South Africa | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Johns Steven L | 17 |
#2 | Erickson Craig A | 9 |
#3 | Doniparthi Badrinath R | 8 |
#4 | Payie Kenneth G | 8 |
#5 | Munianjanappa Shivaraj B | 8 |
#6 | Johns Steven | 7 |
#7 | Doniparthi Badrinath | 6 |
#8 | Payie Kenneth | 6 |
#9 | Erickson Craig | 1 |
Publication | Filing date | Title |
---|---|---|
US2020163895A1 | Formulations of homotaurines and salts thereof | |
CA2993614A1 | Combination therapy using acamprosate and d-cycloserine | |
US2019046458A1 | Sprinkle formulations of acamprosate |